CVA Family Office’s Bio-Rad Laboratories Class A BIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$9.2K Buy
33
+29
+725% +$8.35K ﹤0.01% 1023
2025
Q4
$1.21K Hold
4
﹤0.01% 1073
2025
Q3
$1.12K Buy
+4
New +$1.09K ﹤0.01% 1113
2025
Q2
Sell
-2
Closed -$487 1310
2025
Q1
$487 Sell
2
-67
-97% -$20.2K ﹤0.01% 1282
2024
Q4
$22.7K Hold
69
﹤0.01% 654
2024
Q3
$23.1K Buy
69
+2
+3% +$635 ﹤0.01% 631
2024
Q2
$18.3K Buy
+67
New +$19.5K ﹤0.01% 656
2022
Q3
Sell
-15
Closed -$7K 876
2022
Q2
$7K Buy
15
+5
+50% +$2.6K ﹤0.01% 694
2022
Q1
$6K Buy
10
+5
+100% +$3.01K ﹤0.01% 739
2021
Q4
$4K Buy
+5
New +$3.74K ﹤0.01% 765
2021
Q3
Sell
-5
Closed -$3K 421
2021
Q2
$3K Sell
5
-15
-75% -$9.13K ﹤0.01% 821
2021
Q1
$11K Buy
+20
New +$11.8K ﹤0.01% 506

Other funds holding BIO